Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans
by
Spitzer M, Franke B, Walter H, Buechler J,
Wunderlich AP, Schwab M, Kovar KA, Hermle L, Gron G.
Department of Psychiatry,
University of Ulm,
Leimgrubenweg 12-14,
D-89075 Ulm, Germany.
manfred.spitzer@medizin.uni-ulm.de
Neuropharmacology 2001 Aug;41(2):263-71


ABSTRACT

In a randomised double-blind trial the subjective, neuropsychological and brain activation effects of the two enantiomers of the MDMA (ecstasy-) like drug N-ethyl-3,4-methylenedioxyamphetamine (MDE) were studied in five normal subjects using functional magnetic resonance imaging (fMRI). (S)-MDE produced elevated mood, impairments in conceptually driven cognition and marked right frontal activation. In contrast, (R)-MDE produced increased depression, enhanced visual feature processing, and activation of visual cortical and left frontal areas. Plasma concentrations were higher for the (R)-enantiomer. The so-called entactogenic effects of MDE are likely to be caused by the (S)-enantiomer, whereas (R)-MDE appears to be responsible for neurotoxic effects.

MDE
History
MDMA/MDE
Entactogens
Controversies
Protect and survive
MDE/Eve (from PIHKAL)
Enantiomers of Adam and Eve
Ecstasy and serotonin synthesis
MDE v psilocybin v d-methamphetamine


Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family